Literature DB >> 18925308

Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.

Jingyu Deng1, Han Liang, Dan Sun, Rupeng Zhang, Hongjie Zhan, Xiaona Wang.   

Abstract

BACKGROUND: The purpose of the present study was to provide valuable prognostic information on lymph node-negative gastric cancer patients following curative resection.
METHODS: Data from 112 lymph node-negative gastric cancer patients who underwent curative resection were reviewed to identify the independent factors of overall survival and recurrence.
RESULTS: The five-year survival rate of lymph node-negative gastric cancer patients was 85.7%, and recurrence was identified in 25 patients after curative surgery. The five-year survival rate of lymph node-negative gastric cancer patients was higher than that of lymph node-positive gastric cancer patients (P<0.001). Recurrence in lymph node-negative gastric cancer patients was less than that of lymph node-positive gastric cancer patients (P=0.001). The median survival after recurrence of lymph node-negative gastric cancer patients was longer than that of lymph node-positive gastric cancer patients (P=0.021). Using multivariate analyses, the following results were determined for lymph node-negative gastric cancer patients: sex, operative type and the presence of serosal involvement were independent factors of overall survival; and lymphadenectomy, number of dissected nodes and the presence of serosal involvement were independent factors of recurrence.
CONCLUSIONS: The prognosis of lymph node-negative gastric cancer patients was better than that of lymph node-positive gastric cancer patients. Male sex, subtotal gastrectomy and nonserosal involvement should be considered to be the favourable predictors of postoperative long-term survival of lymph node-negative gastric cancer patients. Conversely, limited lymphadenectomy, few dissected nodes and serosal involvement should be considered to be risk factors of postoperative recurrence of lymph node-negative gastric cancer patients.

Entities:  

Mesh:

Year:  2008        PMID: 18925308      PMCID: PMC2661304          DOI: 10.1155/2008/761821

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  45 in total

1.  Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer.

Authors:  S Abe; M Shiraishi; S Nagaoka; H Yoshimura; D K Dhar; T Nakamura
Journal:  Surgery       Date:  1991-05       Impact factor: 3.982

Review 2.  Clinicopathologic studies of gastric carcinoma.

Authors:  M Mori; K Sugimachi
Journal:  Semin Surg Oncol       Date:  1990

3.  Surgical treatment and outcome for node-negative gastric cancer.

Authors:  Y Maehara; M Tomoda; S Tomisaki; M Ohmori; H Baba; K Akazawa; K Sugimachi
Journal:  Surgery       Date:  1997-06       Impact factor: 3.982

4.  Risk factors predictive of lymph node metastasis in depressed early gastric cancer.

Authors:  Nobutsugu Abe; Takashi Watanabe; Kazufumi Suzuki; Hiromichi Machida; Hiroshi Toda; Yuzo Nakaya; Tadahiko Masaki; Toshiyuki Mori; Masanori Sugiyama; Yutaka Atomi
Journal:  Am J Surg       Date:  2002-02       Impact factor: 2.565

5.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

7.  Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.

Authors:  Jin-Pok Kim; Joo-Ho Lee; Soo-Jin Kim; Hang-Jong Yu; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  1998-03       Impact factor: 7.370

8.  Analysis of 154 actual five-year survivors of gastric cancer.

Authors:  S N Hochwald; S Kim; D S Klimstra; M F Brennan; M S Karpeh
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

9.  Should patients over 80 years old be operated on for colorectal or gastric cancer?

Authors:  S Houry; J Amenabar; A Rezvani; M Huguier
Journal:  Hepatogastroenterology       Date:  1994-12

10.  Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

View more
  27 in total

1.  Risk of recurrence after laparoscopy-assisted radical gastrectomy for gastric cancer performed by a single surgeon.

Authors:  Sang-Ho Jeong; Young-Joon Lee; Soon-Tae Park; Sang-Kyung Choi; Soon-Chan Hong; Eun-Jung Jung; Young-Tae Joo; Chi-Young Jeong; Woo-Song Ha
Journal:  Surg Endosc       Date:  2010-11-12       Impact factor: 4.584

2.  Identification of proteins associated with lymph node metastasis of gastric cancer.

Authors:  Yan Ma; Yan-Feng Li; Tie Wang; Rui Pang; Ying-Wei Xue; Shu-Peng Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-15       Impact factor: 4.553

3.  Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.

Authors:  Yinping Dong; Yiran Qiu; Jingyu Deng; Wei Wang; Zhe Sun; Zhenning Wang; Zhiwei Zhou; Huimian Xu; Han Liang
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-07       Impact factor: 4.553

4.  Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer--a European single-centre experience.

Authors:  Yves Dittmar; Silke Schüle; Alexander Koch; Falk Rauchfuss; Hubert Scheuerlein; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2014-07-23       Impact factor: 3.445

5.  Vascular invasion as an independent predictor of poor prognosis in nonmetastatic gastric cancer after curative resection.

Authors:  Peng Li; Yi-Hong Ling; Chong-Mei Zhu; Wan-Ming Hu; Xin-Ke Zhang; Rong-Zhen Luo; Jie-Hua He; Jing-Ping Yun; Yuan-Fang Li; Mu-Yan Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

6.  Prognostic factors in patients with node-negative gastric cancer: a single center experience from China.

Authors:  Xiaowen Liu; Hong Cai; Yingqiang Shi; Yanong Wang
Journal:  J Gastrointest Surg       Date:  2012-04-10       Impact factor: 3.452

7.  Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases.

Authors:  Theresa L A Jeuck; Christian Wittekind
Journal:  Gastric Cancer       Date:  2014-02-19       Impact factor: 7.370

8.  N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy.

Authors:  Jingyu Deng; Rupeng Zhang; Yuan Pan; Baogui Wang; Liangliang Wu; Xishan Hao; Han Liang
Journal:  Tumour Biol       Date:  2013-11-29

9.  A retrospective study on intensity-modulated radiation therapy combined with chemotherapy after D2 radical surgery for gastric carcinoma.

Authors:  Wenguang Luo; Hongyan Zhang; Yufei Zhao; Lin Wang; Lijun Qi; Jingjing Ran; Lei Liu; Aidong Wu
Journal:  Mol Clin Oncol       Date:  2016-03-07

Review 10.  Clinical significance of lymph node metastasis in gastric cancer.

Authors:  Jing-Yu Deng; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.